Image: Computer Simulation of SARS-CoV-2. Reprinted with kind permission of Janet Iwasa of http://animationlab.utah.edu/cova From Dec. 1, 2021 The CDC confirmed today the first case of the Omicron variant, which is officially known as B1.1.529, in the United States. The most concerning aspect of this new variant is the number of mutations associated with it. Viruses […]
Archive for the ‘Pharmacoepidemiology and Medical Device Safety’ Category
Omicron Variant of SARS-CoV-2: Dec. 1, 2021 update
Posted by Michael A. S. Guth on December 1st, 2021
Combining Research, Safety, and Epidemiology
Posted by Michael A. S. Guth on October 23rd, 2018
Risk Management Consulting (RMC), a health services research firm, offers Research, Safety, and Epidemiology services with experience in the healthcare consulting and biopharmaceutical industries. RMC provides the health care system, biopharmaceutical industry, academia, and the Federal Government with “real-world” data to improve the quality, safety, and affordability of healthcare. RMC’s projects range from retrospective to […]